This study shows that different bacterial profiles in breast tissue exist between healthy women and those with breast cancer. - GreenMedInfo Summary
The microbiota of breast tissue and its association with tumours.
Appl Environ Microbiol. 2016 Jun 24. Epub 2016 Jun 24. PMID: 27342554
Camilla Urbaniak
: In the United States, 1 in 8 women will be diagnosed with breast cancer in her lifetime. Along with genetics, the environment also contributes to disease development but what these exact environmental factors are remain unknown. We have previously shown that breast tissue is not sterile but contains a diverse population of bacteria. We thus believe that the host's local microbiome could be modulating the risk of breast cancer development. Using 16S rRNA amplicon sequencing we show that bacterial profiles differ between normal adjacent tissue from women with breast cancer and tissue from healthy controls. Women with breast cancer had higher relative abundances of Bacillus, Enterobacteriaceae and Staphylococcus Escherichia coli (member of the Enterobacteriaceae family) and Staphylococcus epidermidis, isolated from breast cancer patients, were shown to induce DNA double stranded breaks in HeLa cells using theγH2AX assay. We also found that microbial profiles are similar between normal adjacent tissue and tissue sampled directly from the tumour. This novel study raises important questions as to what role the breast microbiome plays in disease development or progression and how we can manipulate this microbiome for possible therapeutics or prevention.
STATEMENT OF SIGNIFICANCE: This study shows that different bacterial profiles in breast tissue exist between healthy women and those with breast cancer. Higher relative abundances of bacteria, that had the ability to cause DNA damage in vitro, were detected in breast cancer patients, as well as a decrease in some lactic acid bacteria, known for their beneficial health effects, including anti-carcinogenic properties. This study raises the important question as to the role of the mammary microbiome in modulating the risk of breast cancer development.